Patients With RA May Safely Receive ICIs for Cancer Treatment
Researchers studied the effect of preexisting rheumatoid arthritis on risk for mortality and immune-related adverse events among those receiving immune checkpoint inhibitors.
Diagnosis & Disease Information
Survey Reveals Physician Preferences for Treating Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Researchers sought to determine physician preferences for treating patients with relapsed/refractory diffuse large B-cell lymphoma in the third line setting.
Bortezomib Plus R-CHOP May Benefit Certain Molecular Subgroups of DLBCL
Researchers sought to determine whether there were subgroups of patients with DLBCL who would benefit from adding bortezomib to R-CHOP.
AbbVie, Janssen Withdraw Imbruvica Accelerated Approvals for MCL, MZL
The withdrawal of MCL and MZL indication does not affect the other approved indications for Imbruvica.
Genetic Variants and Methotrexate in Primary Central Nervous System Lymphoma
Researchers sought to determine the role of certain genetic variants as biomarkers in primary central nervous system lymphoma.
Many Childhood Cancer Survivors Report Late Effects More Than 15 Years After Diagnosis
Survivors of childhood cancer may experience a range of late effects more than 15 years after diagnosis, a new study suggests.
Pembrolizumab Plus ICE Deemed Effective in Relapsed/Refractory Hodgkin Lymphoma
Pembrolizumab plus ICE chemotherapy appears effective as second-line treatment in patients with transplant-eligible Hodgkin lymphoma.
Tandem Meetings 2023: Research Shows Favorable Results for Lymphoma Subtypes
Research presented at the 2023 Tandem Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR demonstrated favorable results for various types of lymphoma.
Valemetostat Shows Promising Efficacy in Relapsed/Refractory Adult T-cell Leukemia/Lymphoma
Researchers sought to determine whether valemetostat would be safe and effective in patients with relapsed/refractory adult T-cell leukemia/lymphoma.
Novel Genomic Signatures Associated With Predisposition to Hodgkin Lymphoma
Researchers sought to determine which genetic variants could be linked with the predisposition for developing Hodgkin lymphoma.
- Loading...
Loading...
Next post in Lymphoma
Loading... 
Loading...